|
8th - 10th November | ICC Wales, Newport
|
|
|
|
DO YOU ALREADY KNOW THE CLINICAL
RESULTS OF THE DISRUPT PAD III
RANDOMIZED STUDY?
Learn more about the efficacy and safety
of SHOCKWAVE IVL for the treatment
of peripheral injuries.
|
|
|
|
BELOW YOU WILL FIND OUR PORTFOLIO
OF SOLUTIONS FOR THE TREATMENT OF CALCIFIED
LESIONS IN DIFFERENT AREAS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rx only - Prior to use, please reference the Important Safety Information LINK HERE for more information on indications, contraindications, warnings,
precautions and adverse events.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
© 2023 Shockwave Medical Inc. All rights reserved. SPL - 70090 Rev. A
|
|
|
|
|
|
|
|
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
